Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
- Weitere Titel
-
Multivalent funktionalisierte Dextran-Antikörper-Konjugate zur effizienten Zerstörung von Tumorzellen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2020
- Schlagwort
-
Dextran
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek Darmstadt
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:tuda-tuprints-115020
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schneider, Hendrik Peter Günter
- Kolmar, Harald
- Schmitz, Katja
- Universitäts- und Landesbibliothek Darmstadt
Entstanden
- 2020
Ähnliche Objekte (12)
Penetration of Nanobody-Dextran Polymer Conjugates through Tumor Spheroids
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Peptide-conjugated dextran hybrids: Generation of a versatile module for cytosolic delivery of biomolecular cargoes
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoes
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
Anti-idiotype antibodies for biomedical applications
Development of Innovative Bioconjugation Strategies for the Generation of Bi-Specific Antibodies Enabling Targeted Protein Degradation
Variability and viral safety of cell culture media to ensure process performance in the biopharmaceutical industry
Penetration of Nanobody-Dextran Polymer Conjugates through Tumor Spheroids
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Peptide-conjugated dextran hybrids: Generation of a versatile module for cytosolic delivery of biomolecular cargoes
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoes
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
Anti-idiotype antibodies for biomedical applications
Development of Innovative Bioconjugation Strategies for the Generation of Bi-Specific Antibodies Enabling Targeted Protein Degradation
Variability and viral safety of cell culture media to ensure process performance in the biopharmaceutical industry
Penetration of Nanobody-Dextran Polymer Conjugates through Tumor Spheroids
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Peptide-conjugated dextran hybrids: Generation of a versatile module for cytosolic delivery of biomolecular cargoes
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoes
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
Anti-idiotype antibodies for biomedical applications
Development of Innovative Bioconjugation Strategies for the Generation of Bi-Specific Antibodies Enabling Targeted Protein Degradation